Anti-Factor Xa Levels in Low-weight Surgical Patients Receiving Enoxaparin for Venous Thromboembolism Prophylaxis: A Prospective Cohort Study

Enoxaparin is indicated for thromboprophylaxis in non-orthopedic surgical patients at a fixed dose of 40 mg daily. According to the US Food and Drug Administration’s enoxaparin prescribing information, this dose exposes low-weight patients (males < 57 kg, females < 45 kg) to a higher risk of b...

Descripción completa

Detalles Bibliográficos
Autores principales: Hakeam, Hakeam A., Al Duhailib, Zainab, Alsemari, Muhannad, Alwaibah, Reem M., Al Shannan, Madhawi F., Shalhoub, Munirah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427004/
https://www.ncbi.nlm.nih.gov/pubmed/32559127
http://dx.doi.org/10.1177/1076029620931194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427004/
https://www.ncbi.nlm.nih.gov/pubmed/32559127
http://dx.doi.org/10.1177/1076029620931194

Ejemplares similares